Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Business, Policy & Funding » Regulatory News & FDA Approvals » CDC Combined COVID-19/Influenza Test Gets FDA Emergency Use Authorization

CDC Combined COVID-19/Influenza Test Gets FDA Emergency Use Authorization

Jul 03, 2020
|
staff reporter

NEW YORK – The US Food and Drug Administration on Thursday granted Emergency Use Authorization to a molecular diagnostic test from the US Centers for Disease Control and Prevention that can detect and differentiate the viruses that cause COVID-19 and flu.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Move Away From Basic Research?

Nature News reports that recent proposed changes to the US National Science Foundation have raised concerns about a shift away from the agency's focus on basic research.

Noel Rose Dies

Noel Rose, the "father of autoimmunity," has died at 92, the Washington Post reports.

Flush the System

According to CNN, Legionella was discovered in buildings leased by the Centers for Disease Control and Prevention as they reopened following coronavirus pandemic-related closures.

PLOS Papers on Malaria in Southeast Asia, Yellow Fever in Brazil, Dengue Virus Genotyping

In PLOS this week: genetic analysis of malaria parasite populations in Southeast Asia, genomic surveillance of yellow fever virus in São Paulo, and more.

Oct
09
Featured Webinar

Navigating the FDA's EUA Process for Diagnostics in the Present and Future: A Stakeholder Panel Discussion

Sponsored by
PerkinElmer

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.

What's Popular?

In Regulatory News & FDA Approvals

  1. Helix Gets FDA Emergency Use Authorization for NGS-Based COVID-19 Test

  2. Illumina Sees Expanding Sequencing Market in COVID-19 Response, Despite Short-Term Woes

    Premium

  3. Adaptive Biotechnologies Receives Expanded FDA Clearance for ClonoSeq MRD Assay

  4. Cleveland Clinic, Three Other Labs Get FDA EUAs for Coronavirus Tests

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.